Clinical Trial Update: Tinnitus and Treatment With umPEA-LUT [NA]

View source ↗

Summary

This clinical trial update describes the study of umPEA-LUT for tinnitus and neuroinflammation, with a status of not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroinflammation
• Tinnitus

Drugs mentioned

• umPEA-LUT (ultra-micronized Palmitoylethanolamide with luteolin)

Snippet

Sponsor: University of Campania Luigi Vanvitelli | Conditions: Tinnitus, Neuroinflammation | NA | Status: NOT_YET_RECRUITING